Joel Sessions, PA-C | |
205 Marengo St, Florence, AL 35630-6033 | |
(256) 768-8764 | |
Not Available |
Full Name | Joel Sessions |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 205 Marengo St, Florence, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902263163 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | PA-1120 (Alabama) | Secondary |
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joel Sessions, PA-C 108 Grove Park Way, Tuscumbia, AL 35674-8530 Ph: (256) 710-6827 | Joel Sessions, PA-C 205 Marengo St, Florence, AL 35630-6033 Ph: (256) 768-8764 |
News Archive
Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.
Only a small percentage of obese patients who have undergone bariatric surgery to help them control their weight follow up this procedure with further plastic surgery to reshape their bodies and remove excess rolls of skin.
The Seattle-based Infectious Disease Research Institute (IDRI) and Chembio Diagnostics, Inc. have entered into two research and development agreements for the development of rapid diagnostic tests for Leishmaniasis and Leprosy, two "neglected diseases" targeted by IDRI.
Sanford-Burnham Medical Research Institute at Lake Nona announced the selection of the first five research organizations that will participate in the Florida Translational Research Program to advance drug discovery in the state.
Despite guidelines recommending screening for depression in cancer patients, it's been unclear whether interventions designed to treat this depression are effective. A study by the University of Colorado Cancer Center and other institutions, published in the Journal of the National Cancer Institute, changes that.
› Verified 5 days ago